BFB HEALTH (00205) announced its financial results for the year ended December 31, 2024. The company reported revenue of HK$33.117 million, representing a year-on-year increase of 9.84%. The loss attributable to shareholders was HK$5.54 million, which narrowed significantly by 83.99% compared to the previous year. The basic loss per share was HK$0.006.
The substantial reduction in the shareholder-attributable loss was primarily due to a decrease in administrative expenses of approximately HK$7.9 million and an increase in the fair value change on financial assets at fair value through profit or loss of about HK$48.4 million. These factors were partially offset by an increase in sales and distribution costs of around HK$2.9 million, an increase in the provision for impairment losses on financial assets attributable to owners of approximately HK$35.2 million, and a decrease in other net gains and losses of about HK$8.8 million.
Comments